Sales for Pfizer’s COVID-19 vaccine and oral treatment declined nearly 70% annually during the first quarter, underscoring the company’s earnings headaches as heads turned toward weight loss drugs.
Related Keywords
United States , American , Eli Lilly , Pfizer , Novo Nordisk , Covid , Life , Pfizer Vaccine , Pfizer Glp 1 , Pfizer Earnings , Pfizer Stock , Earnings ,
vimarsana.com © 2020. All Rights Reserved.